Neurodevelopmental DisordersNCT05820412
Individualized Assessment of Motor Function and Balance in Intensive Therapy
An observational study of Neurodevelopmental Disorders, run by University of Missouri-Columbia at 1 site in United States.
Trial summary
The goal of this study is to assess the individualized use of technology to assess motor function and balance for ambulatory children participating in an intensive therapy episode of care and determine the effectiveness of the program. Read more about this study
- Who is it for?
- Ages 7 to 17 years
- Conditions the study is for
- Neurodevelopmental Disorders
- What is being tested?
- Intensive interdisciplinary therapy
- How many people
- 4 participants
- Where
- 1 siteUnited States
- Study dates
- 22 May 2023to 31 Dec 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 7 to 17 years
- All sexes
- Child
Study population: Ambulatory children aged 7-17 years old receiving care in an interdisciplinary intensive therapy program.
Who may be able to join
- Ambulatory children 7-17 years old receiving care in an interdisciplinary, intensive therapy program
- GMFCS Levels I and II
- able to follow 2-3 step directions
- English speaking
Who cannot join
- orthopedic surgery in the past year or
- significant visual impairment
- significant hearing impairment.
Trial locations and contacts
1 site in 1 country.
United States1 site
Children's Therapy Center--MU Healthcare
Columbia, Missouri, 65201
About this study
Official title: Individualized Use of a Multi-dimensional Instrumented Assessment of Motor Function and Balance Following an Intensive Therapy Episode of Care
The goal of this study is to assess the individualized use of technology to assess motor function and balance for ambulatory children participating in an intensive therapy episode of care and determine the effectiveness of the program. Children 7-17 years old who can walk and are completing an intensive therapy episode of care will be recruited to participate in this study. Demographic, health history, and PT,OT,ST medical records will be collected. Based on the participant's functional goals, motor function and balance tests will be selected including common balance tests (standing with eyes open, standing with eyes closed), walking, walking and turning, standing up and sitting down from a bench, reaction time, and step down. Participants will be tested before, immediately after, 6 weeks after, and 12 weeks after the episode of care.
Read the detailed description
The goal of this study is to assess the individualized use of instrumented assessment of motor function and balance for ambulatory children participating in an intensive therapy episode of care and determine the effectiveness of the intervention. Children 7-17 with neurodevelopmental diagnosis, GMFCS Levels I and II and completing an intensive therapy episode of care will be recruited to participate in this study. Demographic, health history, and PT,OT,ST medical records will be collected. Based on the participant's functional goals, motor function and balance tests in single and dual conditions will be selected including Romberg balance tests, walking, walking and turning, sit to/from stand, reaction time, and step down administered while participant is recorded using a portable measurement platform which incorporates a custom force plate, Azure Kinect spatial sensor, and interface board. Participants will be tested before, immediately after, 6 weeks after, and 12 weeks after the episode of care. Testing is estimated to last for 45 minutes.
- Conditions
- Neurodevelopmental Disorders
- Being tested
- Intensive interdisciplinary therapy
- Keywords
- technology, neurodevelopmental disorders, pediatrics, rehabilitation, intensive therapy
- Medical subject headings
- Neurodevelopmental Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Intensive interdisciplinary therapyOther
Intensive interdisciplinary therapy includes an intense burst of physical, occupational, and/or speech therapy with high intensity and frequency in a duration (e.g. 3-6 hours/day, 3-5 days/week for 4 weeks)
What is being measured
The primary outcome is the main question the study is designed to answer.
Eyes closed standing on firm surface
center of pressure as a measure of postural control obtained from a forceplate obtained while eyes closed standing on firm surface
Measured: before physical therapy begins
Eyes closed standing on firm surface
center of pressure as a measure of postural control obtained from a forceplate obtained while eyes closed standing on firm surface
Measured: immediately following physical therapy
Eyes closed standing on firm surface
center of pressure as a measure of postural control obtained from a forceplate obtained while eyes closed standing on firm surface
Measured: 6 weeks following physical therapy
Eyes closed standing on firm surface
center of pressure as a measure of postural control obtained from a forceplate obtained while eyes closed standing on firm surface
Measured: 12 weeks following physical therapy
Eyes closed standing on firm surface
joint kinematics (movement strategies) obtained while eyes closed standing on firm surface
Measured: before physical therapy
Eyes closed standing on firm surface
joint kinematics (movement strategies) obtained while eyes closed standing on firm surface
Measured: immediately following physical therapy
Eyes closed standing on firm surface
joint kinematics (movement strategies) obtained while eyes closed standing on firm surface
Measured: 6 weeks following physical therapy
Eyes closed standing on firm surface
joint kinematics (movement strategies) obtained while eyes closed standing on firm surface
Measured: 12 weeks following physical therapy
Walking
speed obtained from spatial sensor
Measured: before physical therapy
Walking
speed obtained from spatial sensor
Measured: immediately following physical therapy
Walking
speed obtained from spatial sensor
Measured: 6 weeks following physical therapy
Walking
speed obtained from spatial sensor
Measured: 12 weeks following
Walking
stride length obtained from spatial sensor
Measured: before physical therapy
Walking
stride length obtained from spatial sensor
Measured: immediately following physical therapy
Walking
stride length obtained from spatial sensor
Measured: 6 weeks following physical therapy
Walking
stride length obtained from spatial sensor
Measured: 12 weeks following physical therapy
5 Times sit to stand test
time to complete obtained from spatial sensor
Measured: before physical therapy
5 Times sit to stand test
time to complete obtained from spatial sensor
Measured: immediately following physical therapy
5 Times sit to stand test
time to complete obtained from spatial sensor
Measured: 6 weeks following physical therapy
5 Times sit to stand test
time to complete obtained from spatial sensor
Measured: 12 weeks following physical therapy
5 Times sit to stand test
knee joint kinematics obtained from spatial sensor
Measured: before physical therapy
5 Times sit to stand test
knee joint kinematics obtained from spatial sensor
Measured: immediately following physical therapy
5 Times sit to stand test
knee joint kinematics obtained from spatial sensor
Measured: 6 weeks following physical therapy
5 Times sit to stand test
knee joint kinematics obtained from spatial sensor
Measured: 12 weeks following physical therapy
Step down
knee joint kinematics obtained from spatial sensor
Measured: before physical therapy
Step down
knee joint kinematics obtained from spatial sensor
Measured: immediately following physical therapy
Step down
knee joint kinematics obtained from spatial sensor
Measured: 6 weeks following physical therapy
Step down
knee joint kinematics obtained from spatial sensor
Measured: 12 weeks following physical therapy
Secondary outcomes (1)
Measures of processes of care
Questionnaire designed to assess parents' perceptions of the care they and their children receive from children's rehabilitation treatment centres. It is a means to assess family-centred behaviours of health care providers.
Measured: immediately following the episode of care
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Apr 2023
- Study start22 May 2023
- Primary completion31 Dec 2023
- Study completion31 Dec 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (7)Papers the sponsor has linked to this study.
- Other trials for Neurodevelopmental DisordersStudies of the same condition, open and under way.
- More trials run by University of Missouri-ColumbiaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 4 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Missouri-Columbia
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Jamie Hall, University of Missouri-Columbia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05820412
- Sponsor's protocol ID
- 2096274
- Status last verified
- Sep 2024
- First submitted
- 22 Mar 2023
- Last updated
- 19 Sep 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Hall JB, Chole D, Pruitt TC, Linkeman K. Caregiver Perceptions of an Interdisciplinary Intensive Therapy Program: A Qualitative Study. Pediatr Phys Ther. 2023 Apr 1;35(2):228-235. doi: 10.1097/PEP.0000000000000994. Epub 2023 Jan 10.
PubMed 36637445Guess TM, Bliss R, Hall JB, Kiselica AM. Comparison of Azure Kinect overground gait spatiotemporal parameters to marker based optical motion capture. Gait Posture. 2022 Jul;96:130-136. doi: 10.1016/j.gaitpost.2022.05.021. Epub 2022 May 21.
PubMed 35635988Thomas J, Hall JB, Bliss R, Guess TM. Comparison of Azure Kinect and optical retroreflective motion capture for kinematic and spatiotemporal evaluation of the sit-to-stand test. Gait Posture. 2022 May;94:153-159. doi: 10.1016/j.gaitpost.2022.03.011. Epub 2022 Mar 21.
PubMed 35334335French MA, Roemmich RT, Daley K, Beier M, Penttinen S, Raghavan P, Searson P, Wegener S, Celnik P. Precision Rehabilitation: Optimizing Function, Adding Value to Health Care. Arch Phys Med Rehabil. 2022 Jun;103(6):1233-1239. doi: 10.1016/j.apmr.2022.01.154. Epub 2022 Feb 15.
PubMed 35181267Gannotti ME. Coupling Timing of Interventions With Dose to Optimize Plasticity and Participation in Pediatric Neurologic Populations. Pediatr Phys Ther. 2017 Jul;29 Suppl 3(Suppl 3 IV STEP 2016 CONFERENCE PROCEEDINGS ):S37-S47. doi: 10.1097/PEP.0000000000000383.
PubMed 28654476Gannotti ME, Christy JB, Heathcock JC, Kolobe TH. A path model for evaluating dosing parameters for children with cerebral palsy. Phys Ther. 2014 Mar;94(3):411-21. doi: 10.2522/ptj.20130022. Epub 2013 Nov 14.
PubMed 24231231Tinderholt Myrhaug H, Ostensjo S, Larun L, Odgaard-Jensen J, Jahnsen R. Intensive training of motor function and functional skills among young children with cerebral palsy: a systematic review and meta-analysis. BMC Pediatr. 2014 Dec 5;14:292. doi: 10.1186/s12887-014-0292-5.
PubMed 25475608
Study at a glance
From the registry record, last updated by the sponsor on 19 Sep 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Individualized Use of a Multi-dimensional Instrumented Assessment of Motor Function and Balance Following an Intensive Therapy Episode of Care
- ClinicalTrials.gov ID
- NCT05820412
- Acronym / sponsor ID
- 2096274
- Conditions
- Neurodevelopmental Disorders
- Keywords
- technology, neurodevelopmental disorders, pediatrics, rehabilitation, intensive therapy
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 4 participants (actual)
- Lead sponsor
- University of Missouri-ColumbiaUniversity, hospital or other
- Study start
- 22 May 2023 (actual)
- Primary completion
- 31 Dec 2023 (actual)
- Study completion
- 31 Dec 2023 (actual)
- First posted
- 19 Apr 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this study is to assess the individualized use of technology to assess motor function and balance for ambulatory children participating in an intensive therapy episode of care and determine the effectiveness of the program. Children 7-17 years old who can walk and are completing an intensive therapy episode of care will be recruited to participate in this study. Demographic, health history, and PT,OT,ST medical records will be collected. Based on the participant's functional goals, motor function and balance tests will be selected including common balance tests (standing with eyes open, standing with eyes closed), walking, walking and turning, standing up and sitting down from a bench, reaction time, and step down. Participants will be tested before, immediately after, 6 weeks after, and 12 weeks after the episode of care.
Detailed description
The goal of this study is to assess the individualized use of instrumented assessment of motor function and balance for ambulatory children participating in an intensive therapy episode of care and determine the effectiveness of the intervention. Children 7-17 with neurodevelopmental diagnosis, GMFCS Levels I and II and completing an intensive therapy episode of care will be recruited to participate in this study. Demographic, health history, and PT,OT,ST medical records will be collected. Based on the participant's functional goals, motor function and balance tests in single and dual conditions will be selected including Romberg balance tests, walking, walking and turning, sit to/from stand, reaction time, and step down administered while participant is recorded using a portable measurement platform which incorporates a custom force plate, Azure Kinect spatial sensor, and interface board. Participants will be tested before, immediately after, 6 weeks after, and 12 weeks after the episode of care. Testing is estimated to last for 45 minutes.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 7 to 17 years
- Sex
- All
- Age groups
- Child
- Study population
- Ambulatory children aged 7-17 years old receiving care in an interdisciplinary intensive therapy program.
Key inclusion criteria (4 listed)
- Ambulatory children 7-17 years old receiving care in an interdisciplinary, intensive therapy program
- GMFCS Levels I and II
- able to follow 2-3 step directions
- English speaking
Key exclusion criteria (3 listed)
- orthopedic surgery in the past year or
- significant visual impairment
- significant hearing impairment.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Intensive interdisciplinary therapyIntensive interdisciplinary therapy includes an intense burst of physical, occupational, and/or speech therapy with high intensity and frequency in a duration (e.g. 3-6 hours/day, 3-5 days/week for 4 weeks) | Other | – |
Primary outcome
Eyes closed standing on firm surface
Time frame: before physical therapy begins
center of pressure as a measure of postural control obtained from a forceplate obtained while eyes closed standing on firm surface
Eyes closed standing on firm surface
Time frame: immediately following physical therapy
center of pressure as a measure of postural control obtained from a forceplate obtained while eyes closed standing on firm surface
Eyes closed standing on firm surface
Time frame: 6 weeks following physical therapy
center of pressure as a measure of postural control obtained from a forceplate obtained while eyes closed standing on firm surface
Eyes closed standing on firm surface
Time frame: 12 weeks following physical therapy
center of pressure as a measure of postural control obtained from a forceplate obtained while eyes closed standing on firm surface
Eyes closed standing on firm surface
Time frame: before physical therapy
joint kinematics (movement strategies) obtained while eyes closed standing on firm surface
Eyes closed standing on firm surface
Time frame: immediately following physical therapy
joint kinematics (movement strategies) obtained while eyes closed standing on firm surface
Eyes closed standing on firm surface
Time frame: 6 weeks following physical therapy
joint kinematics (movement strategies) obtained while eyes closed standing on firm surface
Eyes closed standing on firm surface
Time frame: 12 weeks following physical therapy
joint kinematics (movement strategies) obtained while eyes closed standing on firm surface
Walking
Time frame: before physical therapy
speed obtained from spatial sensor
Walking
Time frame: immediately following physical therapy
speed obtained from spatial sensor
Walking
Time frame: 6 weeks following physical therapy
speed obtained from spatial sensor
Walking
Time frame: 12 weeks following
speed obtained from spatial sensor
Walking
Time frame: before physical therapy
stride length obtained from spatial sensor
Walking
Time frame: immediately following physical therapy
stride length obtained from spatial sensor
Walking
Time frame: 6 weeks following physical therapy
stride length obtained from spatial sensor
Walking
Time frame: 12 weeks following physical therapy
stride length obtained from spatial sensor
5 Times sit to stand test
Time frame: before physical therapy
time to complete obtained from spatial sensor
5 Times sit to stand test
Time frame: immediately following physical therapy
time to complete obtained from spatial sensor
5 Times sit to stand test
Time frame: 6 weeks following physical therapy
time to complete obtained from spatial sensor
5 Times sit to stand test
Time frame: 12 weeks following physical therapy
time to complete obtained from spatial sensor
5 Times sit to stand test
Time frame: before physical therapy
knee joint kinematics obtained from spatial sensor
5 Times sit to stand test
Time frame: immediately following physical therapy
knee joint kinematics obtained from spatial sensor
5 Times sit to stand test
Time frame: 6 weeks following physical therapy
knee joint kinematics obtained from spatial sensor
5 Times sit to stand test
Time frame: 12 weeks following physical therapy
knee joint kinematics obtained from spatial sensor
Step down
Time frame: before physical therapy
knee joint kinematics obtained from spatial sensor
Step down
Time frame: immediately following physical therapy
knee joint kinematics obtained from spatial sensor
Step down
Time frame: 6 weeks following physical therapy
knee joint kinematics obtained from spatial sensor
Step down
Time frame: 12 weeks following physical therapy
knee joint kinematics obtained from spatial sensor
1 secondary outcome
Measures of processes of care
Time frame: immediately following the episode of care
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Sep 2024.
- Background: PubMed 36637445Hall JB, Chole D, Pruitt TC, Linkeman K. Caregiver Perceptions of an Interdisciplinary Intensive Therapy Program: A Qualitative Study. Pediatr Phys Ther. 2023 Apr 1;35(2):228-235. doi: 10.1097/PEP.0000000000000994. Epub 2023 Jan 10.
- Background: PubMed 35635988Guess TM, Bliss R, Hall JB, Kiselica AM. Comparison of Azure Kinect overground gait spatiotemporal parameters to marker based optical motion capture. Gait Posture. 2022 Jul;96:130-136. doi: 10.1016/j.gaitpost.2022.05.021. Epub 2022 May 21.
- Background: PubMed 35334335Thomas J, Hall JB, Bliss R, Guess TM. Comparison of Azure Kinect and optical retroreflective motion capture for kinematic and spatiotemporal evaluation of the sit-to-stand test. Gait Posture. 2022 May;94:153-159. doi: 10.1016/j.gaitpost.2022.03.011. Epub 2022 Mar 21.
- Background: PubMed 35181267French MA, Roemmich RT, Daley K, Beier M, Penttinen S, Raghavan P, Searson P, Wegener S, Celnik P. Precision Rehabilitation: Optimizing Function, Adding Value to Health Care. Arch Phys Med Rehabil. 2022 Jun;103(6):1233-1239. doi: 10.1016/j.apmr.2022.01.154. Epub 2022 Feb 15.
- Background: PubMed 28654476Gannotti ME. Coupling Timing of Interventions With Dose to Optimize Plasticity and Participation in Pediatric Neurologic Populations. Pediatr Phys Ther. 2017 Jul;29 Suppl 3(Suppl 3 IV STEP 2016 CONFERENCE PROCEEDINGS ):S37-S47. doi: 10.1097/PEP.0000000000000383.
- Background: PubMed 24231231Gannotti ME, Christy JB, Heathcock JC, Kolobe TH. A path model for evaluating dosing parameters for children with cerebral palsy. Phys Ther. 2014 Mar;94(3):411-21. doi: 10.2522/ptj.20130022. Epub 2013 Nov 14.
- Background: PubMed 25475608Tinderholt Myrhaug H, Ostensjo S, Larun L, Odgaard-Jensen J, Jahnsen R. Intensive training of motor function and functional skills among young children with cerebral palsy: a systematic review and meta-analysis. BMC Pediatr. 2014 Dec 5;14:292. doi: 10.1186/s12887-014-0292-5.
- Individual participant dataSharing planned: No
Related trials for Neurodevelopmental Disorders
Enrolling by invitationPhase 3
An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD
ADHD
RecruitingPhase 1
Cannabidiol (CBD) in Adults With ASD
Autism Spectrum Disorder
Not yet recruitingPhase 2
Lisdexamfetamine For the Treatment of Conduct Disorder in Children
Conduct Disorder
RecruitingObservational study
Augmenting Parent Management Training for Child Temper Outbursts Using a Digital Tool
Disruptive Behavior Disorders, Conduct Disorder
RecruitingPhase 3
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Schizophrenia, Autism-Related Irritability
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Neurodevelopmental Disorders, run by University of Missouri-Columbia at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Eyes closed standing on firm surface (time frame: before physical therapy begins). The study lists 28 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05820412, which also lists 7 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.